CDKN2A and cervical adenocarcinoma: Cervical adenocarcinoma patients with p16INK4A negativity presented significantly worse PFS and OS than those with p16INK4A positivity (p = 0.018 and p = 0.047, respectively, log-rank test; Fig. 3a,b).